Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

被引:11
|
作者
Kast, Karin [1 ]
Neuhann, Teresa M. [2 ,3 ]
Goergens, Heike [4 ]
Becker, Kerstin [2 ]
Keller, Katja [1 ]
Klink, Barbara [2 ]
Aust, Daniela [5 ]
Distler, Wolfgang [1 ]
Schroeck, Evelin [2 ]
Schackert, Hans K. [4 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gynecol & Obstet, D-01062 Dresden, Germany
[2] Tech Univ Dresden, Inst Clin Genet, D-01062 Dresden, Germany
[3] Ctr Genet Med, Munich, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Surg Res, D-01062 Dresden, Germany
[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Pathol, D-01062 Dresden, Germany
来源
BMC CANCER | 2012年 / 12卷
关键词
NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR GENES; LYNCH-SYNDROME; OVARIAN-CANCER; BREAST-CANCER; BETHESDA GUIDELINES; CASE SERIES; HEREDITARY; RISKS; CARRIERS;
D O I
10.1186/1471-2407-12-531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) and Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC, Lynch Syndrome) are two tumor predisposition syndromes responsible for the majority of hereditary breast and colorectal cancers. Carriers of both germline mutations in breast cancer genes BRCA1 or BRCA2 and in mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 are very rare. Case presentation: We identified germline mutations in BRCA1 and in MSH6 in a patient with increased risk for HBOC diagnosed with endometrial cancer at the age of 46 years. Conclusions: Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Suman J. Ramus
    Lori S. Friedman
    Simon A. Gayther
    Bruce A.J. Ponder
    Lynda G. Bobrow
    Marco van der Looji
    Janos Papp
    Edith Olah
    [J]. Nature Genetics, 1997, 15 : 14 - 15
  • [32] Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
    Henouda, Sarra
    Bensalem, Assia
    Reggad, Rym
    Serrar, Nedda
    Rouabah, Leila
    Pujol, Pascal
    [J]. DISEASE MARKERS, 2016, 2016
  • [33] BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer
    Weiqiu Chen
    Kaifeng Pan
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Benyao Lin
    Youyong Lu
    Weicheng You
    Yuntao Xie
    [J]. Breast Cancer Research and Treatment, 2009, 117 : 55 - 60
  • [34] Two contiguously located germline BRCA1 mutations in a Spanish early-onset breast cancer family
    Díez, O
    Domènech, M
    Cortés, J
    Del Río, E
    Brunet, J
    Alonso, MC
    Baiget, M
    [J]. CANCER LETTERS, 1999, 142 (01) : 71 - 73
  • [35] BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer
    Chen, Weiqiu
    Pan, Kaifeng
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Lu, Youyong
    You, Weicheng
    Xie, Yuntao
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) : 55 - 60
  • [36] Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer
    K. Bell
    N. Hodgson
    M. Levine
    B. Sadikovic
    K. Zbuk
    [J]. Breast Cancer Research and Treatment, 2014, 146 : 447 - 450
  • [37] No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer -: art. no. e22
    Vahteristo, P
    Ojala, S
    Tamminen, A
    Tommiska, J
    Sammalkorpi, H
    Kiuru-Kuhlefelt, S
    Eerola, H
    Aaltonen, LA
    Aittomäki, K
    Nevanlinna, H
    [J]. JOURNAL OF MEDICAL GENETICS, 2005, 42 (04) : e22
  • [38] Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer
    Bell, K.
    Hodgson, N.
    Levine, M.
    Sadikovic, B.
    Zbuk, K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (02) : 447 - 450
  • [39] Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
    de Jonge, Marthe M.
    de Kroon, Cornelis D.
    Jenner, Denise J.
    Oosting, Jan
    de Hullu, Joanne A.
    Mourits, Marian J. E.
    Garcia, Encarna B. Gomez
    Ausems, Margreet G. E. M.
    Collee, J. Margriet
    van Engelen, Klaartje
    van de Beek, Irma
    Group, Hebon
    Smit, Vincent T. H. B. M.
    Rookus, Matti A.
    de Bock, Geertruida H.
    van Leeuwen, Flora E.
    Bosse, Tjalling
    Dekkers, Olaf M.
    van Asperen, Christi J.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (09) : 1203 - 1211
  • [40] Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer
    Campos, Berta
    Balmana, Judith
    Gardenyes, Josep
    Valenzuela, Irene
    Abad, Oscar
    Fabregas, Pere
    Volpini, Victor
    Diez, Orland
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 597 - 602